Other News

Neovasc Announces Progress on COSIRA-II Clinical Trial

VANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced an update on the COSIRA-II Clinical Trial (“Trial”) status. COSIRA-II is the U.S. Investigational Device Exemption (“IDE”) pivotal clinical trial the Company is executing for the Neovasc Reducer™ (“Reducer”) towards an approval […]

Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

Insurer Positive Coverage Decisions Announced KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the ASSURE® Wearable Cardioverter Defibrillator (WCD) system is now available in-network to over 100 million insurance plan members across the U.S. The company reached this covered-lives milestone for the ASSURE WCD system less than one year from when the first […]

Catheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone Hospital

MT. OLIVE, N.J. & CARLSBAD, Calif.–(BUSINESS WIRE)–Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the VIVO System that enables physicians to identify the origin of arrhythmias pre-procedure. On September 12, 2022 privately […]

FEops’ AI-enabled Solution Changes TAVI Pre-procedural Decision in One Third of Patients, Associated With Favorable Clinical Outcomes

GENT, Belgium–(BUSINESS WIRE)–Data from the PRECISE-TAVI study, presented at the PCR Valves 2022 convention in London shows that Transcatheter Aortic Valve Implantation (TAVI) procedures planned by means of FEops HEARTguideTM result in an important change of pre-procedural decision making of the heart team, associated with favorable clinical outcomes. This prospective multicenter […]

T-Heart Appoints Sarah Sorrel as Independent Board Member

PARIS–(BUSINESS WIRE)–T-Heart, a medtech company developing a truly novel and differentiated transcatheter tricuspid prosthetic heart valve specifically designed for tricuspid regurgitation, today announced it has appointed Sarah Sorrel as its first independent member of the Board of Directors. Sarah Sorrel has more than 30 years’ experience in medical device regulation […]

Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making

New partnership incorporates latest perfusion technology into the Viz.ai platform SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will incorporate Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion […]

Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right diagnosis for more patients

 New Ultrasound Compact System 5000 Series delivers premium image quality needed to aid in a confident diagnosis in a portable unit Compatibility with Philips ultrasound systems Affiniti and EPIQ transducers, user interface, workflow, and automation tools allows an easy learning curve for advanced and novice users alike Integration with Philips […]

Dr. Sean Lyden Agrees to Assume the Role of Chief Medical Consultant and Join the VESTECK Scientific Advisory Board

WEST CHESTER, Pa., Nov. 28, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce that, Dr. Sean Lyden has agreed to assume the role of Chief Medical Consultant and also join the VESTECK Scientific Advisory Board. Dr. Lyden is currently the Chairman of the Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold […]

EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT

LONDON, Nov. 27, 2022 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company’s EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes. The data were presented during the late-breaking trials session at PCR London […]